| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/PCAN.2009.63 |
| P698 | PubMed publication ID | 20125121 |
| P2093 | author name string | L Black | |
| E D Crawford | |||
| E J Kruep | |||
| M Eaddy | |||
| P2860 | cites work | Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29619860 |
| The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data | Q30928387 | ||
| Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. | Q33206271 | ||
| Radical prostatectomy versus watchful waiting in early prostate cancer | Q34418166 | ||
| The influence of finasteride on the development of prostate cancer | Q34534815 | ||
| 20-year outcomes following conservative management of clinically localized prostate cancer | Q36115855 | ||
| The changing face of prostate cancer | Q36309672 | ||
| A review of phase III clinical trials of prostate cancer chemoprevention | Q36774297 | ||
| Critical review: is watchful waiting a viable management option for older men with prostate cancer? | Q37502285 | ||
| The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasteride. | Q39317811 | ||
| Primary treatment choices for men with clinically localized prostate carcinoma detected by screening | Q46977038 | ||
| Uncertainty and Quality of Life of Older Men Who Undergo Watchful Waiting for Prostate Cancer | Q53391140 | ||
| Radical retropubic versus laparoscopic prostatectomy: a prospective comparison of functional outcome | Q73739704 | ||
| Radical prostatectomy in a community practice | Q77351999 | ||
| P433 | issue | 2 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 162-167 | |
| P577 | publication date | 2010-02-02 | |
| P1433 | published in | Prostate Cancer and Prostatic Diseases | Q2108326 |
| P1476 | title | A retrospective analysis illustrating the substantial clinical and economic burden of prostate cancer | |
| P478 | volume | 13 |
| Q26738278 | A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer |
| Q33855285 | Active surveillance for low-risk prostate cancer compared with immediate treatment: a Canadian cost comparison |
| Q40666865 | Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer |
| Q57818885 | Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis |
| Q34243421 | Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases |
| Q92462623 | Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer |
| Q35114920 | Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population |
| Q37364597 | Direct cost for initial management of prostate cancer: a systematic review |
| Q36199750 | Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database |
| Q37631848 | Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. |
| Q50246719 | HIFU is effective, but associated morbidity still remains unclear |
| Q36833759 | Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system? |
| Q38113950 | Midterm oncological outcome and clinicopathological characteristics of anterior prostate cancers treated by endoscopic extraperitoneal radical prostatectomy. |
| Q30838052 | Oncologists' response to new data regarding the use of epidermal growth factor receptor inhibitors in colorectal cancer |
| Q44904629 | Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study. |
| Q92100760 | Validation of an Algorithm for Claims-based Incidence of Prostate Cancer |
Search more.